Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("chronic myeloid leukemia")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 413

  • Page / 17
Export

Selection :

  • and

Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: Rapid response to imatinib mesylate (STI571)IMASHUKU, Shinsaku; MORIMOTO, Akira; KURIYAMA, Kikuko et al.Medical and pediatric oncology. 2003, Vol 41, Num 2, pp 159-160, issn 0098-1532, 2 p.Article

Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemiaVERSTOVSEK, Srdan; KANTARJIAN, Hagop; MANSHOURI, Taghi et al.Cancer. 2003, Vol 97, Num 5, pp 1248-1252, issn 0008-543X, 5 p.Article

In vitro sensitivity of hematopoietic progenitors to Tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemiaCOLOVIC, M; SEFER, D; BOGDANOVIC, A et al.Cancer letters. 2003, Vol 195, Num 2, pp 153-159, issn 0304-3835, 7 p.Article

Megakaryocytic blast crisis as first presentation of chronic myeloid leukemiaCAMPIOTTI, L; GRANDI, A. M; BIOTTI, M. G et al.American journal of hematology. 2007, Vol 82, Num 3, pp 231-233, issn 0361-8609, 3 p.Article

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemiaALBANO, F; ANELLI, L; ZAGARIA, A et al.Oncogene (Basingstoke). 2010, Vol 29, Num 17, pp 2509-2516, issn 0950-9232, 8 p.Article

La leucémie myéloïde chronique en 2003 = Chronic myeloid leukemia in the year 2003LEWALLE, P; MARTIAT, P.Revue médicale de Bruxelles. 2003, Vol 24, Num 5, pp 420-430, issn 0035-3639, 11 p.Article

The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemiaGRIFFITHS, Stephen D; BURTHEM, John; UNWIN, Richard D et al.Molecular biotechnology. 2007, Vol 36, Num 2, pp 81-89, issn 1073-6085, 9 p.Article

Clinical cardiac safety profile of nilotinibKIM, Theo D; LE COUTRE, Philipp; SCHWARZ, Michaela et al.Haematologica (Roma). 2012, Vol 97, Num 6, pp 883-889, issn 0390-6078, 7 p.Article

A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αKREIL, Sebastian; WAGHORN, Katherine; ERNST, Thomas et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 148-152, issn 0390-6078, 5 p.Article

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemiaMILOJKOVIC, Dragana; NICHOLSON, Emma; KHORASHAD, Jamshid S et al.Haematologica (Roma). 2010, Vol 95, Num 2, pp 224-231, issn 0390-6078, 8 p.Article

Insights into the stem cells of chronic myeloid leukemiaSLOMA, I; JIANG, X; EAVES, A. C et al.Leukemia. 2010, Vol 24, Num 11, pp 1823-1833, issn 0887-6924, 11 p.Article

Estimations of the Increasing Prevalence and Plateau Prevalence of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitor TherapyXUELIN HUANG; CORTES, Jorge; KANTARJIAN, Hagop et al.Cancer. 2012, Vol 118, Num 12, pp 3123-3127, issn 0008-543X, 5 p.Article

Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemiaBARNES, David J; SCHULTHEIS, Beate; ADEDEJI, Simisade et al.Oncogene (Basingstoke). 2005, Vol 24, Num 42, pp 6432-6440, issn 0950-9232, 9 p.Article

Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemiaBUESCHE, Guntram; GEORGII, Axel; DUENSING, Anette et al.Human pathology. 2003, Vol 34, Num 4, pp 391-401, issn 0046-8177, 11 p.Article

Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instabilityGIEHL, M; FABARIUS, A; FRANK, O et al.Leukemia. 2005, Vol 19, Num 7, pp 1192-1197, issn 0887-6924, 6 p.Article

Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progressionMARKTEL, Sarah; MARIN, David; OLAVARRIA, Eduardo et al.Haematologica (Roma). 2003, Vol 88, Num 3, pp 260-267, issn 0390-6078, 8 p.Article

Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patientsCERVANTES, Francisco; HERNANDEZ-BOIUDA, Juan-Carlos; ODRIOZOIA, Jesus et al.Haematologica (Roma). 2003, Vol 88, Num 10, pp 1117-1122, issn 0390-6078, 6 p.Article

Cytogenetic evolution patterns in CML post-SCTKARRMAN, K; SALLERFORS, B; LENHOFF, S et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 3, pp 165-171, issn 0268-3369, 7 p.Article

Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemiaMESQUITA, Maria Manuel; PESTANA, Ana; MOTA, Alexandra et al.Acta obstetricia et gynecologica Scandinavica. 2005, Vol 84, Num 3, pp 300-301, issn 0001-6349, 2 p.Article

Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation : outcome and prognostic factors. The chronic myeloid leukemia subcommittee of the GETH (Grupo Espaiiol de Trasplante Hemopoyético)MARTINEZ, C; GOMEZ, V; TOMAS, J. F et al.Bone marrow transplantation (Basingstoke). 2005, Vol 36, Num 4, pp 301-306, issn 0268-3369, 6 p.Article

Tyrosine kinase inhibitor therapy can cure chronic myeloid leukemia without hitting leukemic stem cellsLENAERTS, Tom; PACHECO, Jorge M; TRAULSEN, Arne et al.Haematologica (Roma). 2010, Vol 95, Num 6, pp 900-907, issn 0390-6078, 8 p.Article

RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell linesPASTURAL, E; TAKAHASHI, N; DONG, W.-F et al.Oncogene (Basingstoke). 2007, Vol 26, Num 11, pp 1586-1594, issn 0950-9232, 9 p.Article

Molecular mechanisms in C-phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562SUBHASHINI, Jagu; MAHIPAL, Suraneni V. K; REDDY, Madhava C et al.Biochemical pharmacology. 2004, Vol 68, Num 3, pp 453-462, issn 0006-2952, 10 p.Article

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric studyKORKOLOPOULOU, P; VINIOU, N; ANDROULAKI, A et al.Leukemia. 2003, Vol 17, Num 1, pp 89-97, issn 0887-6924, 9 p.Article

Modification of the clonogenic capacity of bone marrow cells from normal individuals by the tyrosine kinase inhibitor STI571PREJZNER, W; KNOPINSKA-POSŁUSZNY, W; MIKOŁAJCZUK, J et al.Clinical and laboratory haematology. 2003, Vol 25, Num 5, pp 293-296, issn 0141-9854, 4 p.Article

  • Page / 17